Filing Details

Accession Number:
0001209191-23-049133
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-12 18:23:25
Reporting Period:
2023-09-11
Accepted Time:
2023-09-12 18:23:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197350 Eric Bjerkholt C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-11 10,000 $29.65 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2023-09-11 110,000 $0.00 110,000 $30.43
Common Stock Restricted Stock Units Acquisiton 2023-09-11 55,000 $0.00 55,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
110,000 2033-09-10 No 4 A Direct
55,000 No 4 A Direct
Footnotes
  1. The price reported on this Form 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $29.61 to $29.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.
  2. 1/4th of the shares subject to the Option will vest one year after September 11, 2023 (the "Vesting Commencement Date") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the VestingCommencement Date.
  3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  4. The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023.